| 发明名称 |
USE OF MYELOPEROXIDASE (MPO) INHIBITORS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT MULTIPLE SYSYEM ATROPHY (MSA) 938 |
| 摘要 |
The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.
|
| 申请公布号 |
US2011207755(A1) |
申请公布日期 |
2011.08.25 |
| 申请号 |
US201113033220 |
申请日期 |
2011.02.23 |
| 申请人 |
ASTRAZENECA AB |
发明人 |
ERIKSSON HAAKAN;POEWE WERNER |
| 分类号 |
A61K31/519;A61P25/00 |
主分类号 |
A61K31/519 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
